Back to search

University of British Columbia

Development of small molecule inhibitors of protein nucleic acid interactions with the use of computer-aided drug discovery tools

Abstract

dc:description

In the realm of the development of cancer therapeutics, a significant portion of the human proteome, including over 1600 transcription factors (TFs), is classified as "undruggable". These proteins, often being critical drivers in various cancers, present unique challenges due to their intricate nature and complex interactions with nucleic acids. Despite these obstacles, they offer a very significant therapeutic potential, necessitating innovative approaches for their exploitation in cancer treatment. This thesis showcases the development and application of Computer-Aided Drug Discovery (CADD) in overcoming the challenges associated with targeting proteins that have been previously deemed ‘undruggable’. Through detailed case studies, it reveals the strategic use of CADD in three distinct scenarios: - For the androgen receptor (AR), CADD leverages the existing experimental data to design novel inhibitors with unique chemotypes; - in case of the RNA-binding protein Lin28, CADD orchestrates the entire drug discovery process, from the identification of the binding site to the optimization of lead compounds; - for targeting HOXB13, a relatively uncharted factor, CADD facilitates navigating selectivity challenges, showcasing the adaptability of these tools in unlocking previously unattainable drug targets. Collectively, these three projects illustrate how CADD can assist in the development of inhibitors that disrupt of protein-nucleic acid interactions across various protein families and stages of drug discovery and addressing numerous CADD challenges. Additionally, this work demonstrates that the utility of CADD is deeply intertwined with experimental validation. By seamlessly integrating computational modeling with experimental workflow, this thesis not only introduces novel methodologies for targeting challenging proteins involved into transcription but also highlights the synergistic potential of advancements in both computational and experimental domains. The outcomes of this research extend the horizons of drug discovery, opening up new avenues for cancer treatment and accelerating the development of innovative therapeutic strategies.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Bioinformatics
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Radaeva, Mariia
Contributors dc:contributor
  • Cherkasov, Artem
  • Dong, Xuesen

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/89202

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Radaeva, Mariia. Development of small molecule inhibitors of protein nucleic acid interactions with the use of computer-aided drug discovery tools. doctoral thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/89202